SCHEMBL14083221

SCHEMBL14083221

CNc1cc(-c2ncccc2Cl)ccc1C(=O)Nc1ccc(OC)nc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ KMT2A Q03164 5/20 0.46
▸ MEN1 O00255 4/20 0.46
▸ KEAP1 Q14145 1/20 0.46
▸ NFE2L2 Q16236 1/20 0.46
▸ TRPV1 Q8NER1 3/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ PABPC1 P11940 2/20 0.44
▸ USP2 O75604 1/20 0.44
▸ HTR2C P28335 1/20 0.44
▸ RAB9A P51151 1/20 0.43
▸ NAMPT P43490 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ GRM4 Q14833 1/20 0.43
▸ CASP3 P42574 1/20 0.42
▸ SENP8 Q96LD8 1/20 0.42
▸ SENP7 Q9BQF6 1/20 0.42
▸ SENP6 Q9GZR1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083339 0.88 SMN1; SMN2 (0.46) POLBSMN1; SMN2KMT2AMEN1KEAP1
SCHEMBL14083223 0.88 TRPV1 (0.48) TRPV1
SCHEMBL14083365 0.87 TRPV1 (0.51) POLBSMN1; SMN2KMT2AMEN1KEAP1
SCHEMBL14083623 0.87 TRPV1 (0.52) POLBSMN1; SMN2KMT2AMEN1KEAP1
SCHEMBL14083178 0.87 KMT2A (0.50) POLBSMN1; SMN2KMT2AMEN1KEAP1
SCHEMBL14083189 0.85 GRM4 (0.54) SMN1; SMN2KMT2AMEN1TRPV1KDM4E
SCHEMBL14083205 0.85 GRM4 (0.57) SMN1; SMN2KMT2AMEN1TRPV1KDM4E
SCHEMBL14083192 0.85 TRPV1 (0.54) KMT2AMEN1TRPV1KDM4ERAB9A
SCHEMBL14083203 0.84 TRPV1 (0.52) KMT2AMEN1TRPV1ALDH1A1GRM4
SCHEMBL14083510 0.83 TRPV1 (0.65) POLBSMN1; SMN2KMT2AMEN1KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 POLB 4543/4885SMN1; SMN2 2099/4885KMT2A 4272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback